Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines

Reproductive Toxicology - Tập 89 - Trang 45-53 - 2019
Lu Li1,2,3, Ling Yin Tang2, Bo Liang2, Rongyun Wang4, Qiuhua Sun4, Clara Bik San Lau3, Ping Chung Leung3, Ellen Fritsche5, Manfred Liebsch6, Andrea E.M. Seiler Wulczyn6, Horst Spielmann7, Chi Chiu Wang1,2,8,9
1College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China
2Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong
3Institute of Chinese Medicine & State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, Hong Kong
4School of Nursing, Zhejiang Chinese Medical University, Hangzhou, China
5IUF-Leibniz Research Institute of Environmental Medicine, Düsseldorf, Germany
6Central Ethics Committee for Stem Cell Research (ZES), Robert Koch Institute, Berlin, Germany
7Institute for Pharmacy, Faculty of Biology, Chemistry, and Pharmacy, Freie Universität, Berlin, Germany
8School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong
9Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong

Tài liệu tham khảo

Flaws, 2005 Li, 2012, Chinese herbal medicines for threatened miscarriage: review, Cochrane Database Syst. Rev., 5 Li, 2013, Systematic review of Chinese Medicine for miscarriage during early pregnancy, Evid.-Based Compl. Altern. Med., 753856, 1 Li, 2012, Adverse outcomes of Chinese medicines used for threatened miscarriage: a systematic review and meta-analysis, Hum. Reprod. Update, 18, 504, 10.1093/humupd/dms025 Wang, 2013, Pregnancy outcomes, embryonic and fetal development in maternal exposure to chinese medicines, Birth Defects Res Part C: Embryo Today, 99, 275, 10.1002/bdrc.21050 Yang, 1992, Study on intellectual development of children with maternal exposure to treatments of threatened miscarriage, Chin. J. Integr. Trad. West. Med., 3, 175 Cui, 1998, Treatment on 47 cases of abortion, Shanxi J. Trad. Chin. Med., 19, 242 Chou, 2002, Clinical observation on 112 cases of abortion treated by supplemented shoutai wuzi soup, J. Youjiang Med. College Nationalities, 2, 301 Zhou, 2006, Clinical observation on Shoutai Pill and Shixiao Powder for the treatment of threatened abortion with kidney deficiency and blood stasis, J. Guangzhou Uni Tradit. Chin. Med., 23, 25 Zhao, 2008, Clinical study of serum CA125: zi Shen Rou Gan formula for early threatened abortion, Sichuan J. Trad. Chin. Med., 11, 88 Wang, 2012, Safety evaluation of commonly used Chinese medicines during pregnancy in mice, Hum. Reprod., 27, 10.1093/humrep/des180 Li, 2011, Potential reproductive toxicity of Largehead Atractylodes Rhizome, the most commonly used Chinese medicine for threatened miscarriage, Hum. Reprod., 26, 3280, 10.1093/humrep/der335 Tang, 2012, Molecular studies of the congenital malformation induced by Largehead Atractylodes Rhizome, the most commonly used Chinese medicine for threatened miscarriage, Mol. Hum. Reprod., 18, 585, 10.1093/molehr/gas034 Sairafianpour, 2001, Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: new source of tanshinones, J. Nat. Prod., 64, 1398, 10.1021/np010032f Moallem, 2008, Study of embryotoxicity of Perovskia abrotanoides, an adulterant in folk-medicine, during organogenesis in mice, J. Ethnopharmacol., 117, 108, 10.1016/j.jep.2008.01.020 Bremer, 2004, The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development, Curr. Pharm. Des., 10, 2733, 10.2174/1381612043383700 Genschow, 2002, The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods, Altern. Lab. Anim., 30, 151, 10.1177/026119290203000204 Ouedraogo, 2012, Review of current and "omics" methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms, J. Ethnopharmacol., 14, 492, 10.1016/j.jep.2012.01.059 Brown, 2002, Selection of test chemicals for the ECVAM International Validation Study on in vitro embryotoxicity tests, Altern. Lab. Anim., 30, 177, 10.1177/026119290203000205 Curren, 1995, The role of prevalidation in the development, validation and acceptance of alternative methods, Altern. Lab. Anim., 23, 211, 10.1177/026119299502300206 2010 Balls, 1990, Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures, Altern. Lab. Anim., 18, 313, 10.1177/026119299001800131.1 National Institute of Environmental Health (NIEHS), 1999 Organisation for Economic Co-operation and Development (OECD), 1996 Seiler, 2011, The validated embryonic stem cell test to predict embryotoxicity in vitro, Nat. Protocols, 6, 961, 10.1038/nprot.2011.348 2011 Spielman, 2004, Validation of the rat limb bud micromass test in the International ECVAM Validation Study on three in vitro embryotoxicity tests, Altern. Lab. Anim., 32, 245, 10.1177/026119290403200306 Piersma, 2004, Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests, Altern. Lab. Anim., 32, 275, 10.1177/026119290403200307 Lee, 2012, A paradoxical teratogenic mechanism for retinoic acid, Proc. Natl. Acad. Sci. U. S. A., 109, 13668, 10.1073/pnas.1200872109 Ufer, 2008, Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence binding factor 1 is essential for embryonic brain development, Gene Dev., 22, 1835, 10.1101/gad.466308 Maele-Fabry, 1990, Morphogenesis and quantification of the development of post-implantation mouse embryo, Toxicol. In Vitro, 4, 149, 10.1016/0887-2333(90)90037-T Genschow, 2000, Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study, In Vitr. Mol. Toxicol., 13, 51 Leung, 2002, Are herbal medicinal products less teratogenic than Western pharmaceutical products, Acta Pharmacol. Sin., 23, 1169 Awang, 1991, Maternal use of ginseng and neonatal androgenization, JAMA, 266, 363, 10.1001/jama.1991.03470030063021 Cunningham, 2005, Drugs commonly used in pregnancy. Teratology, drugs, and other medications Holst, 2008, Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome, Pharmacoepidem Dr S, 17, 151, 10.1002/pds.1527 Brown, 1995, Screening chemicals for reproductive toxicity: the current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM workshop 12), Altern. Lab. Anim., 23, 868, 10.1177/026119299502300615 Spielmann, 1998, Reproduction and development, Environ. Health Perspect., 106, 571 Bal-Price, 2015, International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes, Arch. Toxicol., 89, 269, 10.1007/s00204-015-1464-2 Fritsche, 2018, Development of the concept for stem cell-based developmental neurotoxicity evaluation, Toxicol. Sci., 165, 14, 10.1093/toxsci/kfy175 Fritsche, 2018, Current availability of stem cell-based in vitro methods for developmental neurotoxicity (DNT) testing, Toxicol. Sci., 165, 21, 10.1093/toxsci/kfy178